Historic Fed Overlap Powell and Warsh Set for First Joint FOMC Meeting in June Everspin Technologies and the AI Edge Opportunity What Investors Should Know Dhanuka Agritech Announces 70 Crore Share Buyback and 2 Dividend Record Date Set Claros Mtg CMTG Stock Analysis Flat at 211 Whats Next 20260519 NovoCure Holds Gains Near Key Resistance After Modest Uptick Denso Faces Legal Scrutiny ExEmployee Loses Lawsuit Over 19Year Termination and Retrenchment Benefits Nuveen Core Plus Impact Fund NPCT Holds Steady at 994 Amid Rangebound Trading Japans DBJ Eyes Extended Investment Horizon to Bolster Reshoring Push Microsoft Appoints Jenny LayFlurrie to Lead Responsible AI Development Amid Speed vs Safety Tension Signos Secures 20 Million Funding with Dexcom Partnership to Advance AIPowered Health Tracking Amid GLP1 Weight Loss Trend US Stock Futures and Bond Yields Slide After Reports of Updated Russian Nuclear Doctrine Burberry Shares Surge on Reports of Potential Moncler Acquisition Bid Market Talks Roundup DeepSeek and SoFi Feature in Tech Media Telecom Discussions Singapore Manufacturing Output Rises in April AI Demand Fuels Growth Across Most Sectors GOOGL Q1 2026 Earnings EPS Misses Amid Accelerated AI Investments FDX Q1 2026 Earnings EPS Surges 26 Above Estimates on Cost Discipline ICE Q1 2026 Earnings EPS Surpasses Estimates Amid Modest Stock Decline ALGS Q1 2026 Earnings NarrowerThanExpected Loss as Aligos Therapeutics Advances Pipeline Ernexa Therapeutics ERNA Q3 2023 Earnings ClinicalStage Biotech Reports Net Loss as Stock Declines Bicara Therapeutics BCAX Q1 2026 Earnings EPS Miss Overshadowed by Pipeline Progress as Stock Rises 4 Acorn Energy Inc ACFN Q4 2025 Earnings Profitability Despite Limited Disclosures EML Q1 2026 Earnings EPS Falls Short of Estimates by 782 Sonic Automotive Q1 2026 Earnings Strong EPS Beat Lifts Shares FIX Q1 2026 Earnings Massive EPS Beat Drives Strong Performance Despite Revenue Data Gap CZWI Q1 2026 Earnings EPS Beats Estimates Revenue Data Not Disclosed Eli Lillys Retatrutide Shows Strong Phase 3 Results CNBC Reports Xenon Pharmaceuticals XENE Q1 2026 Earnings Narrowerthanexpected loss highlights operational progress